Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Insulin-dependent diabetes mellitus is caused by autoimmune destruction of the insulin-producing beta cells resident in the pancreatic islets. We recently discovered that the pathogenesis of
diabetes
in
NOD
strain mice was associated with T-cell reactivity to an antigen cross-reactive with a mycobacterial 65-kDa heat shock protein. To identify peptide epitopes critical to the insulin-dependent
diabetes mellitus
of
NOD
mice, we studied the specificities of helper T-cell clones capable of causing hyperglycemia and
diabetes
. We now report the identification of a functionally important peptide within the sequence of the human variant of the 65-kDa heat shock protein molecule. T-cell clones recognizing this peptide mediate insulitis and hyperglycemia. Alternatively, the T cells can be attenuated and used as therapeutic T-cell vaccines to abort the diabetogenic process. Moreover, administration of the peptide itself to
NOD
mice can also down-regulate immunity to the 65-kDa heat shock protein and prevent the development of
diabetes
. Thus, T-cell vaccination and specific peptide therapy are feasible in spontaneous autoimmune
diabetes
.
...
PMID:Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. 170 31
Insulin-dependent (Type 1)
diabetes mellitus
is recognized as an autoimmune disease and islet-cell antibody (ICA) is present in the majority of patients at diagnosis. ICA labels both beta and alpha cells and is believed to be directed against a glycolipid. In this study we examine the presence of sulphatide (3'-sulphogalactosylceramide) or closely related structures (sulpholactosylceramide and seminolipid) in islet cells by means of a monoclonal antibody, Sulph I. Histological examination of pancreatic tissue from Lewis and BB rats, and BALB/c and
NOD
mice showed a pronounced labelling of the islets of Langerhans with Sulph I. No staining of the exocrine pancreatic tissue, the heart, the liver, the adrenals, the thymus, the spleen or lymph nodes was seen, but staining of some tubular cells and glomerular cells in the kidney as well as of myelin in nerve cells was found. Cytological examination of isolated Lewis islet cells and their cell subpopulations, separated using a fluorescence-activated cell sorter (FACS), showed positive surface labelling of 97.3 +/- 2.2% (SD) of the beta cells and 84.4 +/- 3.0% of the non-beta cells. Thus, the epitope on the glycolipid sulphatide or closely related structures is--with the exception of neural and certain kidney tissue--specifically present in islet cells. Furthermore, the staining pattern of the antibody used, Sulph I, was equivalent to that of ICA.
...
PMID:Pancreatic islet-cell epitope recognized by an anti-sulphatide monoclonal antibody. 172 82
Insulin-dependent diabetes mellitus (IDDM) involves the destruction of the insulin-producing cells in the islets of Langerhans. One possible cure is by transplanting the islet cells; however, transplanted islets, even between identical twins, are subject to autoimmune destruction by the disease process, resulting in
diabetes
recurrence. We recently reported that complete Freund's adjuvant (CFA), an immunomodulating agent, prevented development of autoimmune
diabetes
in the
NOD
mouse. In this study, we evaluated adjuvant therapy in prevention of autoimmune destruction and rejection of transplanted islets in diabetic
NOD
mice. After transplantation, untreated syngeneic islet recipients (n = 16) initially became normoglycemic and then hyperglycemic, with a median survival time (MST) of the graft of 17 days. When CFA was administered at the time of transplantation, 11 of 13 CFA-treated syngeneic islet recipients remained normoglycemic long term (greater than 100 days) with an MST greater than 107 days. Ten of 11 mice maintained indefinite normoglycemia until the conclusion of follow-up (101 to 172 days). When adjuvant therapy was used in conjunction with allogeneic islet transplantation, graft survival was not extended, with MST being similar to the untreated allogeneic islet recipients (12 [n = 5] and 13 [n = 5] days, respectively). The extended acceptance of second syngeneic islet grafts by CFA-treated mice indicates that the persistent autoimmunity against the transplanted islets can be reversed in the diabetic
NOD
mice after CFA treatment.
Diabetes
1992 Jan
PMID:Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. 172 30
NOD
mice develop spontaneous insulin-dependent
diabetes mellitus
(IDDM) associated with infiltration of pancreatic islets with mononuclear cells. Islet infiltration results in autoimmune destruction of insulin-secreting beta-cells. Because in humans and BB rats
diabetes
is often associated with autoimmune thyroid disease (ATD), the
NOD
mouse model was examined for evidence of thyroiditis and serum antibodies reactive with mouse thyroid membrane antigens (MTMAs). The incidence of thyroiditis was 77% in mice greater than 180 days old, 67% in mice 61-180 days old, 72% in mice 31-60 days old, 74% in mice 21-30 days old, 78% in mice 11-20 days old, and 90% in mice less than or equal to 10 days old.
NOD
mice less than or equal to 30 days old had less-severe thyroiditis than animals greater than 180 days old. There was no significant different in severity of thyroiditis between any of the other age-groups tested. The incidence of thyroiditis was not increased in diabetic compared with nondiabetic animals, nor was an association found between thyroiditis and sex. The high incidence of thyroiditis in the less than or equal to 30-day-old age-group indicates that infiltration of lymphocytes into the thyroid can precede initiation of insulitis in this model. Although both thyroiditis and insulitis in
NOD
mice began early (by the 1st and 2nd mo of life, respectively), no significant association between infiltration of these two organs was noted in individual mice.(ABSTRACT TRUNCATED AT 250 WORDS)
Diabetes
1992 Jan
PMID:High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. 172 38
NOR/Lt is an insulitis-resistant and
diabetes
-free strain produced from an isolated genetic contamination within an
NOD
/Lt pedigree line. The albino coat-color phenotype, strain-specific endogenous retroviral profile, and skin graft tests indicated an
NOD
/Lt x C57BL/KsJ outcross-backcross segregant as the source of the contaminating genome. Analysis of 53 polymorphic DNA, biochemical, and immunologic markers distinguishing
NOD
/Lt from C57BL/KsJ revealed that 4 chromosomes (chromosomes 2, 4, 11, and 12) in NOR/Lt contained C57BL/KsJ-derived genes. The remaining markers on 14 chromosomes, including the diabetogenic H-2g7 complex on chromosome 17, were of
NOD
origin. Although completely resistant to cyclophosphamide-induced
diabetes
, NOR/Lt mice exhibited the same peripheral T-lymphocyte accumulation characteristic of
NOD
/Lt. Similarly, NOR/Lt peritoneal macrophages exhibited depressed interleukin-1 secretion characteristic of
NOD
/Lt. In addition to their
diabetes
resistance, NOR/Lt mice were distinguished from
NOD
/Lt by exhibiting more robust suppressor T-lymphocyte function. Outcross of NOR/Lt with
NOD
/Lt to generate heterozygosity at those chromosomal segments, defined by C57BL/KsJ markers in NOR/Lt parentals, did not produce insulitis or
diabetes
in F1 females. However, these F1 females were sensitive to cyclophosphamide-induced
diabetes
. In summary, the NOR/Lt strain is an MHC-matched
diabetes
-resistant control strain for
NOD
/Lt. Moreover, NOR/Lt will help identify the location and function of a non-MHC gene or genes capable of conferring resistance against insulitis and
diabetes
.
Diabetes
1992 Jan
PMID:NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. 172 42
Besides the thymus-dependent immune system, growing evidence suggests that the functional state of the beta cell plays a role in the pathogenesis of Type 1 (insulin-dependent)
diabetes
. Increased incidence of
diabetes
has been described after increased insulin production and vice versa, and actual hyperinsulinemia has been observed in relation to the diabetogenesis. Prophylactic insulin treatment and intensive insulin therapy at diagnosis are discussed. The studies referred to are mostly animal model investigations of BB rats and
NOD
mice and-to a lesser degree- of streptozotocin- and encephalomyocarditis-virus-induced
diabetes
. Also human evidence exists, but naturally of a more sporadic character. Three possible mechanisms behind the beta cell sensitivity as a function of their activity are suggested: increased antigen expression (including both gangliosides and proteins) in beta cells with high activity which could activate the destruction caused by the immune system, and increased susceptibility to the toxicity of interleukins and to diabetogenic agents. With respect to developing preventive treatment the described research area may turn out to be very important. Further studies both in animal models and in humans are awaited.
...
PMID:The functional state of the beta cells in the pathogenesis of insulin-dependent diabetes mellitus. 174 24
We have recently reported that systemic and chronic administration of recombinant tumour necrosis factor alpha (TNF-alpha), as well as streptococcal preparation (OK-432), inhibits development of insulin-dependent
diabetes mellitus
(IDDM) in
NOD
mice and BB rats, models of IDDM. In this study we examined whether serum containing endogenous TNF induced by OK-432 injection could inhibit IDDM in
NOD
mice. Treatment twice a week from 4 weeks of age with OK-432-injected mouse serum, which contained endogenous TNF (75U), but not IL-1, IL-2 and interferon-gamma (IFN-gamma) activity, reduced the intensity of insulitis and significantly inhibited the cumulative incidence of
diabetes
by 28 weeks of age in
NOD
mice, as compared with the incidence in non-treated mice (P less than 0.01) and in mice treated with control serum (P less than 0.02). This inhibitory effect of the serum was diminished, although not significantly, by neutralization of serum TNF activity with anti-mouse TNF antibody. In the mice treated with the serum from OK-432-injected mice, Thy-1.2+ or CD8+ spleen cells decreased (P less than 0.01) and surface-Ig+ (S-Ig+) cells increased (P less than 0.05), whereas the proliferative response of spleen cells to concanavalin A (P less than 0.01) and lipopolysaccharide (P less than 0.05) increased. The results indicate that the inhibition by OK-432 treatment of IDDM in
NOD
mice was partially mediated by serum factors including endogenous TNF.
...
PMID:Inhibition of autoimmune diabetes in NOD mice with serum from streptococcal preparation (OK-432)-injected mice. 174 49
This study analyzed T-lymphocyte-receptor V beta genes of infiltrating lymphocytes into the pancreases of 12- to 16-wk-old
NOD
mice with severe insulitis and 5-wk-old mice with mild insulitis by the quantitative polymerase chain reaction method. The V beta transcripts on infiltrating T lymphocytes into pancreases with severe insulitis in older
NOD
mice were diverse. In contrast, the V beta 11 gene transcript was predominantly expressed on T lymphocytes in the pancreas in younger
NOD
mice with mild insulitis, suggesting the possible role of V beta 11+ T lymphocytes in triggering insulitis in this species.
Diabetes
1991 Dec
PMID:T-lymphocyte-receptor repertoire of infiltrating T lymphocytes into NOD mouse pancreas. 175 99
T cells and antibodies against self and non-self hsp are present in both patients and healthy controls. T cells responding to hsp65 can be involved in autoimmune diseases, this was demonstrated for two site-specific animal autoimmune diseases: AA in Lewis rats and
diabetes
(IDDM) in
NOD
mice. In human ReA there is evidence for a direct stimulation of joint T cells by antigens of the organisms causing the infection which precedes the joint inflammation. The individual antigens of the triggering bacteria still have to be defined, but hsp65 may be of importance since this is one of the molecules recognized by synovial T cells in ReA patients. In RA there are no clear data implicating an infection in the initiation of joint inflammation, but mycobacteria have been suggested to be involved. We have discussed experimental findings which are in favor of, or in contradiction with, a role of mycobacterial antigens--particularly hsp65--in the etiology of RA. T cells recognizing hsp65 and other mycobacterial antigens are present in the joint, but there is no indication for a specific involvement of one or a limited set of (myco)bacterial antigens in the pathogenesis of RA.
...
PMID:Heat-shock proteins and autoimmunity in humans. 177 20
Fifteen spontaneously diabetic, non-obese mice (
NOD
strain), 17 non-diabetic
NOD
mice (in which
diabetes
had not yet developed) and 9 diabetic
NOD
mice were treated with insulin. All animals were superovulated with 5 iu of pregnant mares' serum gonadotrophin followed 48 h later by 5 iu human chorionic gonadotrophin (hCG) and mated overnight with
NOD
males of proven fertility. To assess in-vitro and early in-vivo development, 23
NOD
mice were killed 72 h after hCG treatment. Embryos were recovered from oviduct flushings and cultured in Ham's F-10 medium with 0.1% bovine serum albumin at 37 degrees C in an atmosphere of 5% O2, 5% CO2, and 90% N2. Development was assessed at intervals of 24 h for 72 h. Compared with embryos from non-diabetic
NOD
mice (n = 81), embryos from diabetic
NOD
mice (n = 68) demonstrated marked impairment in growth assessed by distribution of developmental stages at each observation period (24, 48, 72 h, all P less than 0.001) and by overall rates of progression of developmental stages (P less than 0.01). In diabetic
NOD
mice treated with insulin, embryo development (n = 7) was not significantly different from that of embryos from non-diabetic
NOD
mice (n = 81), but was significantly faster than in embryos from diabetic
NOD
mice not treated with insulin (n = 68) (P less than 0.001, for all periods, overall rate P less than 0.01). To assess late in-vivo growth, 18
NOD
mice were killed 120 h after hCG.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Effect of diabetes mellitus on mouse pre-implantation embryo development. 178 51
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>